怀孕期间的长度血氨基酸和新生儿人类学:来自NICHD胎儿生长研究-Singleton队列的研究结果
Claire Guivarch1,2,3, Jing Wu4, Ruijin Lu5
1Global Centre for Asian Women's Health, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.
BMC medicine
|June 8, 2025
概括
怀孕期间母亲的氨基酸 (AA) 水平显著影响胎儿的生长. 特定的AA度,如谷氨酸和甘氨酸,在怀孕早期测量,与出生体重和长度相关,突出显示它们在新生儿人类学中的关键作用.
科学领域:
- 产科和妇科 产科和妇科
- 孕产妇和胎儿医学 孕产妇和胎儿医学
- 营养科学 营养科学
背景情况:
- 氨基酸 (AAs) 在怀孕期间对胎儿发育至关重要.
- 以前对怀孕期间AAs的研究经常使用单个时间点测量,未能捕捉动态变化.
- 这项研究通过在整个妊娠期间纵向评估血AA概况来弥补这一差距.
研究的目的:
- 为了研究血氨基酸的纵向度与新生儿人类测量指标之间的关联.
- 了解怀孕期间特定氨基酸的波动如何与胎儿生长结果有关.
主要方法:
- 血样本从321名怀孕妇女在多个妊娠周 (10-14,15-26,23-31,33-39GW) 收集.
- 测量了关键氨基酸 (芳香,分支链,单碳代谢) 的度.
- 使用加权的通用估计方程来分析AA第三种动物和新生儿人类学之间的关联,并调整混因素.
主要成果:
- 10-14吉瓦的较高谷氨胺水平与更高的出生体重z-score和长度有关.
- 23-31GW的高酸与较小的皮相相关.
- 在10-14吉瓦时增加的甘氨酸与较低的出生体重z-score有关.
结论:
- 怀孕期间的血氨基酸度与新生儿人体测量具有关键关联.
- 这些关联早在10个妊娠周就可检测到.
- 氨基酸对胎儿生长的影响因特定的AA类型和妊娠年龄而异.
相关概念视频
Nature and Nurture
19.4K
Many human characteristics, like height, are shaped by both nature—in other words, by our genes—and by nurture, or our environment. For example, chronic stress during childhood inhibits the production of growth hormones and consequently reduces bone growth and height. Scientists estimate that 70-90% of variation in height is due to genetic differences among individuals, and 10-30% of variation in height is due to differences in the environments that individuals experience,...
19.4K
Longitudinal Research
11.7K
Sometimes we want to see how people change over time, as in studies of human development and lifespan. When we test the same group of individuals repeatedly over an extended period of time, we are conducting longitudinal research. Longitudinal research is a research design in which data-gathering is administered repeatedly over an extended period of time. For example, we may survey a group of individuals about their dietary habits at age 20, retest them a decade later at age 30, and then again...
11.7K
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
982
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
982
Pharmacokinetics in Pediatric Patients: Drug Distribution
562
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
562


